In a groundbreaking development, Elon Musk’s Neuralink has achieved a significant milestone by successfully implanting its innovative brain chip, named Telepathy, in a human being.
The announcement was made by Musk on his social media platform, X (formerly Twitter), where he expressed optimism about the early results of the procedure.
The recipient, a participant in Neuralink’s inaugural human test group, underwent the implantation on a Sunday and is reportedly recovering well, according to Musk.
Initial findings suggest promising neuron spike detection, indicating a positive outcome for the cutting-edge neurotechnology.
Elon Musk elucidates that Telepathy, the brain chip, empowers users to control their phones, computers, and a wide range of devices through mere thoughts.
Musk envisions a future where individuals can communicate at speeds surpassing those of a professional typist or auctioneer, drawing a parallel to the potential communication abilities of the late Stephen Hawking.
Neuralink’s first human trial specifically targets individuals who have lost the use of their limbs, emphasizing the company’s commitment to improving the quality of life for those facing physical limitations.
The trial aims to assess both the safety of the implant and the efficacy of the surgical robot responsible for inserting the chip into the brain.
The FDA granted clearance for this pivotal trial in May, marking a significant regulatory milestone. It is crucial to note that this trial is just one step in the extensive process leading to final FDA approval.
Neuralink seeks to validate the safety of its technology and evaluate its real-world functionality before achieving regulatory green light.